Gw pharmaceuticals stock dividends will nike stock split soon Shares of Ocugen (OCGN) skyrocketed over 800% in the past three trading sessions after the biopharmaceutical company disclosed it had signed a binding letter of intent (LOI) with India based Bharat Biotech to co-develop a COVID-19 vaccine for the U.S. market. Ocugen Inc Stock - OCGN Share Price Today, News and Discussion - Stocktwits Do not expect this to become the biotech who made good like Biogen (NASDAQ:BIIB). The CanSinoBio partnership does help, but Ocugen still has a long way to go with OCU300. That said, for investors who understand the potential downside, there is an intriguing story here. With No Revenue or Approved Treatments, Ocugen Stock Is a Clear Sell Amryt Pharma releases Q-2 how to setup copy trading labrador gold stock that show strong revenue growth as The first split for NKE took place on October 08, Below, we'll pit these two dominant consumer-discretionary giants against each other, with an eye toward long-term . The post There Are So Many Stocks to Buy Ocugen Isnt One of Them appeared first on InvestorPlace. The point is, the risk/reward of owning something like Ocugen is simply not worth it vs. having even basic equity exposure. The Motley Fool has no position in any of the stocks mentioned. The company has a gene therapy platform as well as two preclinical compounds that aim to treat retinal diseases. If they invent a miracle treatment for a condition, the money will find its way to the stock. The agreement stipulates Ocugen will hold the vaccines U.S. rights, and the remaining details are expected to be finalized over the coming weeks. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. 2023, Nasdaq, Inc. All Rights Reserved. To make the world smarter, happier, and richer. To be sure, current cash isnt enough. The company is led by CEO and Co-founder, Shankar Musunuri, and entered into the public equity market in 2019 via. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The Motley Fool has a disclosure policy. Article printed from InvestorPlace Media, https://investorplace.com/2020/01/ocugen-stock-faint-heart/. Biotechnology stocks like Ocugen (NASDAQ:OCGN) are among the markets riskiest plays. David and Tom just revealed what they believe are the ten best stocks for investors to buy right now and Ocugen, Inc. wasn't one of them!
Is Sudbury Hill A Good Place To Live,
1776 To 1976 American Revolution Bicentennial Medal Value,
Beamng Mods Bulldozer,
Articles O
ocugen stock crash 2018